PulmoBioTech is a publically listed company which trades on the NASDAQ OTC (symbol PLMO).
Garry McCann, Director & CEO
Garry, age 49, is also the Managing Director of MC&C td, a UK business consulting company. Prior to these positions he was the Managing Director of NE Technology Ltd, a global leader in the design and manufacture of radiation detection equipment. Garry has also been active in the fields of CAT X-ray generators, medical imaging CCDs and IR Image Sensors. Garry has an MBA from Warwick University Business School and a BSc in Physics from the University of Surrey.
Peter B. Hirshfield
The current share structure can be seen in the most recently filed 10-Q for
the quarter ended June 30, 2009.
This is available at:
****No additional shares have been issued since those reported in the 10-Q.****
Hope that helps
Estimated Market Cap $37,888,253 as of Oct 23, 2009
Outstanding Shares 52,622,574 as of 10/28/09
Authorized Shares 250,000,000 as of 10/28/09